The flow cytometry market size is estimated to be USD 5,120.81 million in 2022 and is expected to witness a CAGR of 10.75% during the forecast period 2023-2033. The increasing use of flow cytometry methods in academic and research settings, escalating rates of cancer, HIV/AIDS, and AIDS worldwide, expanding public-private collaborations for research in immunology and immuno-oncology, advancements in flow cytometry software, and growing use of AI platforms in the process are factors contributing to the market growth. However, significant technology expenses, lack of qualified and experienced workers, and challenges with reagent manufacturing is expected to hinder the growth.

Segmentation

 By Product and Service

Based on product and service, the market is segregated into instruments, reagents and consumables, software, services, and accessories. In 2022, the reagents and consumables segment held the highest market share owing to the production and sale of superior assays and reagents tailored to particular applications, and ongoing need for flow cytometry supplies from end customers.

 By Application

On the basis of application, the market is bifurcated into research applications, and industrial applications. In 2022, the research applications segment held the highest market share due to rising R&D spending in the biotechnology and pharmaceutical industries and the growing research and development efforts in the areas of cancer and infectious diseases.

 By Technology

Based on technology, the market is bifurcated into bead-based flow cytometry, and cell-based flow cytometry. In 2022, the cell-based flow cytometry segment held the highest market share owing to its ability to evaluate compound activity against molecular targets while interacting with live cells and expanding the market for cell-based flow cytometry.

 By End User

Based on end user, the market is segregated into pharmaceutical & biotechnology companies, academic & research institutes, and hospitals & clinical testing laboratories. In 2022, the pharmaceutical & biotechnology companies segment held the highest market share due to the increasing food industry in emerging nations like China and India, and expanding commercial entities’ involvement in R&D, such as pharmaceutical and biotechnology firms.

Regional Markets

In 2022, North America region accounted for the highest revenue in the flow cytometry market and is expected to maintain its dominance during the forecast period. This is attributed to the high costs for healthcare, developed healthcare framework, strong uptake of cutting-edge flow cytometry solutions in the United States, the existing pharmaceutical sector, and intensive research activities by research universities and pharmaceutical businesses, and rising frequency of infectious and chronic illnesses. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the significant expansion of the pharmaceutical and biotechnology sectors in developing nations like China and India, ongoing government assistance for the development of the pharmaceutical sector in developing nations, and constant research and development initiatives in the fields of cancer and infectious diseases.

Competitor Insights

Some of the key players operating in the flow cytometry market are Agilent Technologies, Inc. (US), Apogee Flow Systems Ltd (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc (US), Danaher Corporation (US), Luminex Corporation (US), Miltenyi Biotec (Germany) Sony Biotechnology, Inc (US), Stratedigm, Inc (US), Sysmex Corporation (Japan), and Thermo Fisher Scientific, Inc. (US).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product and service, application, technology and end user from 2023 to 2033.

Report Scope:

Segmentation: Flow Cytometry Market Report 2022 – 2033

Product and Service (Revenue, USD Million), 2022 – 2033

• Instruments
  • Cell Sorters
    • Low-range
    • Mid-range
    • High-range
  • Cell Analyzers
    • Low-range
    • Mid-range
    • High-range
  • Reagents and Consumables
  • Software
  • Services
  • Accessories

Application (Revenue, USD Million), 2022 – 2033

• Research Applications
  • Pharmaceuticals and Biotechnology
    • In Vitro Toxicity Testing
    • Drug Discovery
    • Stem Cell Research
  • Cell Sorting
  • Immunology
  • Cell Cycle Analysis
  • Apoptosis
  • Cell Counting
  • Cell Viability
  • Other Research Applications
• Clinical Applications
  • Hematology
  • Cancer Diagnostics
  • Organ Transplantation
  • Autoimmune Diseases
  • Other Clinical Applications
• Industrial Applications

Technology (Revenue, USD Million), 2022 – 2033

• Bead-based Flow Cytometry
• Cell-based Flow Cytometry

By End User (Revenue, USD Million), 2022 – 2033

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Clinical Testing Laboratories

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA